Health Technology Assessment (HTA)

Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.

Operationalising Value Based Pricing
News

New: Operationalising Value Based Pricing

11 August 2011

To date, the UK Government has not been specific about how VBP will be implemented, but has indicated that calculations of value will extend beyond the…

Ruth Puig-Piero
News

Does Relative Effectiveness Vary Across Europe?

9 August 2011

At the Spanish Health Economics Association (AES) conference in May 2011, OHE’s Ruth Puig Peiró discussed a recent OHE study that reviewed the available literature on…

News

Previews of Forthcoming Publications

27 July 2011

OHE is making available as Occasional Papers drafts of two important chapters that will appear in the Oxford Handbook on the Economics of the Pharmaceutical Industry…

News

Join us for the 2011 Annual Lecture

19 July 2011

The 2011 OHE Annual Lecture — Cost per QALY in the U.S. and Britain: Damned if You Do and Damned if You Don’t? — will be…

News

Measuring Value with Pharmacoeconomics

26 May 2011

In forthcoming chapter in the Oxford Handbook on the Economics of the Biopharmaceutical Industry, experts in the field outline the evolution of cost-effectiveness analysis (CEA) through…

Is the Aim of Health Care Systems to Maximise QALYs?
News

QALYs v. Other Criteria in NHS Decisions

17 May 2011

Just released is an OHE Research Paper that examines whether and how decisions about allocating resources for health care differ across the NHS and, particularly, in…

News

Incorporating Multiple Criteria in HTA

19 April 2011

This OHE publication is intended to inform and stimulate debate about the way different sorts of evidence and considerations are taken into account in decisions about…

News

The Spanish Medicines Market Today

9 February 2011

Spending by Spain’s National Health Service (NHS) on pharmaceuticals was €12.1 billion in 2010. Its market for prescription medicines is among the slowest growing in Europe,…

News

Comparing Variants of Lead and Lag Time TTO

1 February 2011

OHE was awarded a UK Department of Health grant to further develop three aspects of health status indexes. Results of the second of these, advances in…